Navigation Links
Matinas BioPharma to Present at the NYC Medical Technology Forum on February 5, 2013
Date:2/4/2013

TEWKSBURY, N.J. and TARPON SPRINGS, Fla., Feb. 4, 2013 /PRNewswire/ -- Matinas BioPharma, Inc., a biopharmaceutical company focused on the commercialization and development of omega-3-based prescription therapeutics for the treatment of metabolic and cardiovascular conditions, announced today that Roelof Rongen , Matinas BioPharma's Chief Executive Officer, is scheduled to present at the NYC Medical Technology Forum on Tuesday, February 5, 2013 at 6 PM EST.

Mr. Rongen's presentation will include the Company's business outlook for 2013, an overview of the development of its lead product candidate, MAT9001 and its key milestones expected over the next 12 months.  Matinas BioPharma is developing MAT9001 for therapeutic applications, with severe hypertriglyceridemia (TG>500 mg/dL) and mixed dyslipidemia (TG 200-499 mg/dL) as the lead indications.  Based on promising early data, the Company is preparing to file an Investigational New Drug Application (IND) with the U.S. Food and Drug Administration (FDA) and conduct a human study in 2013.  Following positive data from this study, Matinas expects to commence its Phase 3 registration program in the first half of 2014. 

About Matinas BioPharma

Matinas BioPharma Inc. is a privately-held biopharmaceutical company focused on the development of omega-3-based prescription therapeutics for the treatment of metabolic and cardiovascular conditions.  The Company is developing the investigational drug MAT9001 for therapeutic applications with severe hypertriglyceridemia (TG>500 mg/dL) and mixed dyslipidemia (TG 200-499 mg/dL).  Matinas is building on its extensive, proprietary research and development capabilities of its founding management team.  The Matinas BioPharma team brings a cumulative multi-decade omega-3 pharmaceutical development experience to the Comp
'/>"/>

SOURCE Matinas BioPharma
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Keryx Biopharmaceuticals Announces Pricing of Public Offering of Common Stock
2. PDL BioPharma Announces Departure of Finance VP
3. PDL BioPharma Announces 2013 Regular Quarterly Dividends
4. Keryx Biopharmaceuticals Announces $55 Million Proposed Public Offering of Common Stock
5. FDAnews announces Biopharmaceutical Good Distribution Practices Summit
6. Robbins Arroyo LLP Announces the Filing of a Securities Fraud Class Action Lawsuit Against Hemispherx Biopharma, Inc.
7. Robust Biopharmaceutical Pipeline Offers New Hope for Patients
8. Aequus BioPharma Appoints Ronald J. Berenson, M.D. President and CEO
9. AAIPharma Appoints Senior Director of Biopharmaceutical Development
10. PDL BioPharma Announces Resignation of Chief Financial Officer
11. Pressure BioSciences Announces Conversion of All Remaining Series E Convertible Preferred Stock by Ironridge BioPharma
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/22/2015)... 2015  RegeneRx Biopharmaceuticals, Inc. (OTCQB: RGRX), a clinical-stage ... regeneration, today announced that J.J. Finkelstein , chief ... corporate overview at two upcoming investor conferences. ... th Annual Microcap Conference on Thursday May 28, ... at 11:00 am EDT.  A webcast will be available ...
(Date:5/22/2015)... 2015  RegeneRx Biopharmaceuticals, Inc. (OTCQB: RGRX) ("the ... of the results of the Company,s 72-patient, placebo-controlled ... drops) for the treatment of dry eye patients ... ) model.  The exploratory study was completed in ... disseminated by the Company in a press release, ...
(Date:5/22/2015)... May 20, 2015 Research and Markets( ... "Guide to Prepare Application Dossiers for Oversea ... Edition) " report to their offering. ... of segment market of the most growth potentiality, ... device manufacturers and producers to penetrate such market. ...
Breaking Medicine Technology:RegeneRx to Present at 2 Investor Conferences 2RegeneRx to Present at 2 Investor Conferences 3Complete Data from RegeneRx Phase II Dry Eye Trial Published in Current Issue of Clinical Ophthalmology 2Complete Data from RegeneRx Phase II Dry Eye Trial Published in Current Issue of Clinical Ophthalmology 3Complete Data from RegeneRx Phase II Dry Eye Trial Published in Current Issue of Clinical Ophthalmology 4China Guide to Prepare Application Dossiers for Oversea Medical Device Registration and Recordation 2China Guide to Prepare Application Dossiers for Oversea Medical Device Registration and Recordation 3
... Mass., Oct. 26, 2011 Idenix Pharmaceuticals, Inc. (NASDAQ: ... financial results for the third quarter of 2011 on Wednesday, ... Idenix management will host a conference call at 4:30 p.m. ... financial results for the third quarter of 2011 and provide ...
... 2011 /PRNewswire-iReach/ -- UBM Medica today announced ... features content dedicated to the latest developments in the ... other major rheumatologic diseases. (Photo:   http://photos.prnewswire.com/prnh/20111026/CG93984 ... have altered the landscape of rheumatology and the quality ...
Cached Medicine Technology:Idenix to Host Conference Call Discussing Third Quarter and Nine Month 2011 Financial Results and Announces Presentations at the American Association for the Study of Liver Diseases Meeting (AASLD) 2UBM Medica's Musculoskeletal Network Highlights Changing Rheumatologic Landscape 2UBM Medica's Musculoskeletal Network Highlights Changing Rheumatologic Landscape 3
(Date:5/22/2015)... May 22, 2015 Memorial Day weekend is ... Insurance is offering some tips to help promote safe ... there will be 383 traffic fatalities this Memorial Day weekend. ... National Highway Traffic Safety Association: , , ... vehicle is wearing a seatbelt, whether they’re driving or riding ...
(Date:5/22/2015)... MOUNTAIN VIEW, California (PRWEB) May 22, 2015 ... Breakers, has set a RecordSetter.com World Record at the 104th ... Coco Libre coconut water ice luge served 315 people in ... Zappos.com Bay to Breakers race is so true to the ... that we felt bringing an ice luge to the finish ...
(Date:5/22/2015)... 22, 2015 The dentist ... announces that they are now offering complimentary consultations ... dental treatments. At consultations, patients can discuss their ... what certain treatments can achieve and whether alternative ... this initial appointment. If treatments are chosen, patients ...
(Date:5/22/2015)... sweetFrog Enterprises, LLC. is pleased to announce the ... now the 16th sweetFrog store located in the Lone Star ... on the Inc. 500 list of fastest growing companies in ... East Texas for 20 years and love the natural beauty ... and nearby Palestine, sweetFrog locations. “We are really excited about ...
(Date:5/22/2015)... May 22, 2015 DMG Productions announces ... scheduled to broadcast on Friday, May 29, 2015 at ... Channel. , In this episode Innovations will explore Interstate ... to business quickly through disaster recovery and restoration. , ... that works collaboratively to develop and deliver training and ...
Breaking Medicine News(10 mins):Health News:Amica Has 4 Road Safety Tips for Memorial Day Weekend 2Health News:Coco Libre Ice Luge Sets New World Record at Bay to Breakers 2Health News:West Hollywood Dental Office, Sunset Plaza Dental is Now Offering Complimentary Consultations 2Health News:sweetFrog Opens New Location in Jacksonville, Texas 2Health News:New Episode of Innovations Airing Friday, May 29, 2015 Via Discovery Channel 2
... GORDONSVILLE, Va., May 28 PBM Holdings, Inc., ... announced today that,its Chinese affiliate company, PBM (Guangzhou) ... of the China earthquake. PBM is,partnering with the ... Red,Cross, an affiliate of the Red Cross Society ...
... in helping ... and stay on therapy, DENVER, May 28 Nearly all ... their commitment to,managing their disease in every way possible is their ... survey of people with,MS, results of which were released today at ...
... Study estimates savings of more than $60 million over 11 ... use of air bags and seat belts significantly reduces injuries ... crash and also lowers in-hospital death rates, injury severity and ... , It also suggests that optimal use of air bags ...
... published in the May 2008 (volume 8, issue 25) ... (pic-noj-en-all), an antioxidant plant extract from the bark of ... type II diabetes patients, allows people to lower ... factors. The study, conducted at the University of Arizona, ...
... The old,saying, "beauty is in the eye ... study in a recent issue of Plastic and ... Society of Plastic,Surgeons (ASPS), found that variations in ... your facial expressions, and,subsequent mood, are perceived by ...
... China Sky One,Medical, Inc. (Amex: CSY ) ... and distributor of pharmaceutical, medicinal and,diagnostic products in ... Public Accountants and Advisors LLP (,Moore Stephens,) as ... terminated its,contract with Sherb & Co., LLP that ...
Cached Medicine News:Health News:PBM Companies Partner with the Red Cross to Donate Infant Formula to China Earthquake Victims 2Health News:Significant Barriers Prevent People with MS from Fully Committing to Treatment Regimen, New Survey Reveals 2Health News:Significant Barriers Prevent People with MS from Fully Committing to Treatment Regimen, New Survey Reveals 3Health News:Significant Barriers Prevent People with MS from Fully Committing to Treatment Regimen, New Survey Reveals 4Health News:Significant Barriers Prevent People with MS from Fully Committing to Treatment Regimen, New Survey Reveals 5Health News:Significant Barriers Prevent People with MS from Fully Committing to Treatment Regimen, New Survey Reveals 6Health News:Air Bags-Seat Belts Cut Injuries, Deaths, Costs 2Health News:Study shows pine bark naturally reduces cardiovascular risk factors in diabetics 2Health News:Study shows pine bark naturally reduces cardiovascular risk factors in diabetics 3Health News:Looking Tired or Angry May Have More to do With Facial Aesthetics Than How You Feel, ASPS Study Reveals 2Health News:Looking Tired or Angry May Have More to do With Facial Aesthetics Than How You Feel, ASPS Study Reveals 3Health News:China Sky One Medical, Inc. Engages Moore Stephens as New Independent Auditor 2Health News:China Sky One Medical, Inc. Engages Moore Stephens as New Independent Auditor 3
Provides a combination of concentrated cold / hot and compression for the knee...
Provides a combination of concentrated cold / hot and compression for the wrist...
Provides compression, support, immobilization for the knee in addition to cold / hot therapy...
... One-Piece™ Collar is completely injected molded from ... our patented chin support. , ,Our ... efficiently managed where space is limited. Color-coded ... of sizes., ,Either in a supine ...
Medicine Products: